Receive our Infusion Center Revenue Integrity White Paper
For oncology practices, the infusion center is both the clinical core and the financial engine of the organization. Drug acquisition costs, reimbursement variability, complex coding rules, and payer scrutiny converge at the infusion chair – creating a high-stakes revenue environment where small discrepancies can translate into significant financial exposure.
As margins tighten and payer policies evolve, infusion revenue integrity can no longer rely on manual oversight and retrospective audits. Oncology leaders must adopt a structured, technology-enabled framework that protects reimbursement accuracy at the unit level while supporting operational scale.
This resource outlines the financial anatomy of infusion billing, identifies where revenue leakage occurs, and presents a leadership model for strengthening infusion revenue integrity – supported by automated expected-versus-actual payment modeling and infusion-level visibility through ImagineOne.